Despite several recent advancements in the field of prostate cancer (PC) treatment, there remain distinct gaps in the current ...

CARLSBAD, Calif.--(BUSINESS WIRE)--One-year data from the Nalu COMFORT randomized control trial (RCT) published in the peer-reviewed Regional Anesthesia & Pain Medicine journal confirm the consistent ...

- CT1812 Treatment Showed ~40% Mean Improvement in Cognitive Measures vs Placebo -- Consistent Positive Changes Across Cognitive and Functional Measures -- Favorable Safety Profile with Most Treatment ...

SHANGHAI & CAMBRIDGE, Mass. & BAAR, Switzerland--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor ...

Nov 1 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Friday its weight-loss drug met the main goal of a late-stage trial in patients with a type of fatty liver disease by reducing scarring ...

Medically reviewed by Allison Herries, RDN Key Takeaways Probiotics can help restore balance in the gut and may relieve ...

Aficamten is an investigational drug candidate currently under regulatory review in the U.S; the Food and Drug Administration ...

An Akero Therapeutics drug in development for the fatty liver disease MASH now has clinical trial results showing the experimental treatment reversed organ scarring, bringing patients back from an ...

WALTHAM, Mass., March 16, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with ...

Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up scientific discovery.